Abstract:e341were 46 (28.2%) aboriginals, 3 (1.8%) incarcerated, and 3 (1.8%) living in a long term care facility. Forty-one (24.0%) were new patients and 83 (48.5%) had treatment failure or relapse. Exclude the new patients of our MDR program, 25 (19.8%) developed both isoniazid and rifampin resistance within one year of starting anti-tuberculosis treatment, and 81 (64.3%) developed resistance after more than two years of treatment. Drug resistance was highest against fluoroquinolone (49%).Conclusion: Having prior tre… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.